Howe & Rusling Inc Catalent, Inc. Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $1,195 - $1,390	10 Added 38.46%	36 $5,000
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $100 - $115	-1 Reduced 3.7%	26 $3,000
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $1,015 - $1,252	-10 Reduced 27.03%	27 $3,000
Q4 2020 Feb 08, 2021	SELL	$85.88 - $105.36 $257 - $316	-3 Reduced 7.5%	37 $4,000
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $1,478 - $2,518	40 New	40 $2,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.